Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-26 Purchase |
2024-01-30 4:23 pm |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner |
282,632 | $32.24 | $9,111,941 | 725,000 (Indirect) |
View |
2022-08-10 Purchase |
2022-08-12 09:43 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Millian Craig Stuart Chief Operating Officer |
5,000 | $0.2545 | $1,273 | 27,000 (Direct) |
View |
2022-08-10 Purchase |
2022-08-11 09:55 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
3,800 | $0.264 | $1,003 | 98,230 (Direct) |
View |
2022-08-10 Purchase |
2022-08-10 10:16 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Moran Sean F. Chief Financial Officer |
20,000 | $0.2599 | $5,198 | 199,272 (Direct) |
View |
2022-05-16 Purchase |
2022-05-16 11:03 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Moran Sean F. Chief Financial Officer |
12,000 | $0.3 | $3,600 | 179,272 (Direct) |
View |
2022-05-16 Purchase |
2022-05-16 10:41 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
10,500 | $0.25 | $2,625 | 94,430 (Direct) |
View |
2022-03-10 Purchase |
2022-03-11 11:23 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Millian Craig Stuart Chief Operating Officer |
10,000 | $0.37 | $3,700 | 22,000 (Direct) |
View |
2022-03-10 Purchase |
2022-03-10 11:47 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Moran Sean F. Chief Financial Officer |
15,000 | $0.37 | $5,550 | 167,272 (Direct) |
View |
2022-03-09 Purchase |
2022-03-09 10:37 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
8,600 | $0.37 | $3,182 | 83,930 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-26 Exercise |
2024-01-30 6:07 pm |
2014-02-28 2024-01-29 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | HOLMER ALAN F Director |
629 | $4.97 | 1,379 (Direct) |
View |
2024-01-26 Exercise |
2024-01-30 4:56 pm |
2014-02-28 2014-01-29 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
7,179 | $4.97 | 7,179 (Direct) |
View |
Ownership |
2024-01-30 4:18 pm |
N/A N/A |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner |
0 | $0 | 442,368 (Indirect) |
View |
2023-05-18 Option Award |
2023-05-22 4:33 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Altmeyer Anne Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:32 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jenkins John Kenneth Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:27 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:24 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Salzmann Peter Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:22 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | HOLMER ALAN F Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Ben Yong Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-05-18 Option Award |
2023-05-22 4:17 pm |
N/A 2033-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | CATLIN AVERY W Director |
5,300 | $0 | 5,300 (Direct) |
View |
2023-03-06 Option Award |
2023-03-07 10:19 am |
N/A 2023-03-06 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Ben Yong Director |
5,307 | $0 | 5,307 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 12:56 pm |
N/A 2033-02-13 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Brake Rachael Louise Chief Scientific Officer |
1,400,000 | $0 | 1,400,000 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 12:53 pm |
N/A 2033-02-13 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Millian Craig Stuart Chief Operating Officer |
934,645 | $0 | 934,645 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 12:51 pm |
N/A 2033-02-13 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Moran Sean F. Chief Financial Officer |
934,645 | $0 | 934,645 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 12:44 pm |
N/A 2033-02-13 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
1,989,546 | $0 | 1,949,546 (Direct) |
View |
2022-09-26 Option Award |
2022-09-28 09:38 am |
N/A 2022-09-26 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Altmeyer Anne Director |
159,200 | $0 | 159,200 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:41 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jacques Rachelle Suzanne Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:38 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | HOLMER ALAN F Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:36 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jenkins John Kenneth Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:34 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Salzmann Peter Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 2:23 pm |
N/A 2032-05-18 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | CATLIN AVERY W Director |
79,600 | $0 | 79,600 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:55 pm |
N/A 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Millian Craig Stuart Chief Operating Officer |
402,900 | $0 | 402,900 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:51 pm |
N/A 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
1,489,700 | $0 | 1,489,700 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:49 pm |
N/A 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Brake Rachael Louise Chief Scientific Officer |
570,800 | $0 | 570,800 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:46 pm |
N/A 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Moran Sean F. Chief Financial Officer |
538,400 | $0 | 538,400 (Direct) |
View |
2021-12-06 Option Award |
2021-12-08 4:04 pm |
N/A 2031-12-06 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Brake Rachael Louise Chief Scientific Officer |
500,000 | $0 | 500,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-17 4:45 pm |
N/A 2031-06-17 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Salzmann Peter Director |
116,400 | $0 | 116,400 (Direct) |
View |
2021-06-17 Option Award |
2021-06-17 4:43 pm |
N/A 2031-06-17 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Jenkins John Kenneth Director |
116,400 | $0 | 116,400 (Direct) |
View |